Georgia's Online Cancer Information Center

COVID-19 Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = COVID-19
Cancer Type = COVID-19
There are currently 3 active COVID-19 clinical trials in Georgia.
1.
ASCO Survey on COVID-19 in Oncology (ASCO) Registry
Cancer Type
COVID-19, Hematopoietic Malignancies, Solid Tumor
NCT ID
NCT04659135
Protocol IDs
Pro00014181
NCI-2021-00737
2.
Best Supportive Care with or without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 Infection
Cancer Type
COVID-19
NCT ID
NCT04433949
Protocol IDs
RAD5049-20
NCI-2020-04061
STUDY00000781
3.
Head and Neck cancERs International cOviD-19 collabOraTion
Cancer Type
COVID-19, Head and Neck Cancer, Thyroid Cancer
NCT ID
NCT04632173
Protocol IDs
HERODOTUS
NCI-2021-11878
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.